NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Precision Biosciences logo
Precision BioSciences, a Durham-based genome editing company, has created a new name and brand identity for its food and agriculture business: Elo Life Systems.
World Environment Day

World Environment Day has helped raise awareness of environmental concerns such as: depletion of the ozone layer, toxic chemicals, desertification and global warming. Since it began in 1974, it has grown to become a global platform for public outreach that is widely celebrated in over 100 countries. 

North Carolina has previously celebrated the event by cleaning some public areas as part of the Adopt-A-Highway program. North Carolina is also a coastal state with a wealth of natural resources. Keeping plastics out of the ocean is also a big challenge in the state. 

BioGENEius Challenge
Sumani Nunna, a senior at the North Carolina School of Science and Mathematics in Durham, was one of the 15 finalists for the International BioGENEius Challenge, a major science competition for high school students.
Award photo
Three North Carolina life science companies and four universities were recently recognized for creating employee-friendly workplaces.
Forsyth Tech logo
Forsyth Technical Community College in Winston-Salem has won a $579,961 grant from the National Science Foundation (NSF) to define the workforce skills technicians will need for manufacturing jobs at the intersection of biomedical devices and tissue engineering.
bluebird bio logo
bluebird bio, a gene therapy company with operations in Durham, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration for Lenti-D, its potential treatment for a rare and life-threatening neurological disorder in boys.
AveXis logo
AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs. 
Dova logo
Dova Pharmaceuticals of Durham has received approval from the U.S. Food and Drug Administration for its first commercial drug, a tablet for treating thrombocytopenia, or low blood platelet counts, which can cause dangerous bleeding.
Thad Wadas (from second left with Dr. Jeong Hoon Park) meet with students during a scientific and cultural exchange in Seoul, South Korea.
Thaddeus Wadas, Ph.D., assistant professor of cancer biology at the Wake Forest University School of Medicine whose research has been funded by the North Carolina Biotechnology Center, has gained international recognition for his achievements in cancer imaging and radiotherapy research.
Success in precision health requires teamwork. -- iStock photo
Precision medicine is opening the door to enormous opportunity. And that’s driving an influential group of leaders from academia, business and government—through the North Carolina Precision Health Collaborative — to establish our state as one of the country’s key precision health knowledge hubs.
Stratera Logo

Statera Environmental Inc., a North Carolina State University spinout, has started selling its uniquely sensitive technology for assessing the bioavailability and chronic exposure of chemicals in water and air.

Renovion Logo
Renovion, a Durham pharmaceutical company developing a therapy for chronic inflammatory airway diseases, has added $350,000 in private equity to the $1.8 million raised in 2017.
ACT logo
Advanced Chemotherapy Technology of Raleigh is developing an implantable device to infuse chemotherapy drugs directly into the pancreas, targeting difficult-to-reach tumors while largely sparing surrounding tissues, organs and blood vessels. 
Three bioscience executives from industry and academia have been appointed to roles on the Advisory Committee for Biotechnology in the Piedmont Triad, which advocates for bioscience development in the region, and the Committee’s Executive Advisory Council.
URO-1 logo
URO-1, a medical device startup company in Winston-Salem, has received approval from the U.S. Food and Drug Administration to begin marketing its first product, a new system using existing endoscopes for injecting Botox into the bladder to treat overactive bladder.